Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Torres

Showing results (1111-1120 of 1,246) with videos related to

Pageof 125
Sort By:
Royal Society Open Science|March 29, 2020
<i>ALOX5</i>, <i>LPA</i>, <i>MMP9</i> and <i>TPO</i> gene polymorphisms increase atherothrombosis susceptibility in middle-aged MexicansRafael Camacho-Mejorado, Rocío Gómez, Luisa E Torres-Sánchez, et al.
Kidney International Reports|March 18, 2021
Characteristics of Patients with End-Stage Kidney Disease in ADPKDShehbaz S Shukoor, Lisa E Vaughan, Marie E Edwards, et al.
Kidney International|March 19, 2015
Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies ConferenceArlene B Chapman, Olivier Devuyst, Kai-Uwe Eckardt, et al.
The Prostate|May 5, 2021
Characterization of tumor-associated macrophages in prostate cancer transgenic mouse modelsAmber E de Groot, Kayla V Myers, Timothy E G Krueger, et al.
Kidney International|September 24, 2017
Common Elements in Rare Kidney Diseases: Conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies ConferenceSégolène Aymé, Detlef Bockenhauer, Simon Day, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 10, 2017
Can we further enrich autosomal dominant polycystic kidney disease clinical trials for rapidly progressive patients? Application of the PROPKD score in the TEMPO trialEmilie Cornec-Le Gall, Jaime D Blais, Maria V Irazabal, et al.
Journal of the American Geriatrics Society|July 17, 2013
Inappropriate medication prescriptions in elderly adults surviving an intensive care unit hospitalizationAlessandro Morandi, Eduard Vasilevskis, Pratik P Pandharipande, et al.
Annals of Surgical Oncology|December 11, 2012
Long-term outcomes in patients with radiation-associated angiosarcomas of the breast following surgery and radiotherapy for breast cancerKeila E Torres, Vinod Ravi, Katherine Kin, et al.
Kidney International|June 14, 2013
Evidence of a third ADPKD locus is not supported by re-analysis of designated PKD3 familiesBinu M Paul, Mark B Consugar, Moonnoh Ryan Lee, et al.
Journal of the American Society of Nephrology : JASN|June 22, 2007
Comprehensive molecular diagnostics in autosomal dominant polycystic kidney diseaseSandro Rossetti, Mark B Consugar, Arlene B Chapman, et al.
Pageof 125

Showing results (1111-1120 of 1,246) with videos related to

Sort By:
Pageof 125
Royal Society Open Science|March 29, 2020
<i>ALOX5</i>, <i>LPA</i>, <i>MMP9</i> and <i>TPO</i> gene polymorphisms increase atherothrombosis susceptibility in middle-aged MexicansRafael Camacho-Mejorado, Rocío Gómez, Luisa E Torres-Sánchez, et al.
Kidney International Reports|March 18, 2021
Characteristics of Patients with End-Stage Kidney Disease in ADPKDShehbaz S Shukoor, Lisa E Vaughan, Marie E Edwards, et al.
Kidney International|March 19, 2015
Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies ConferenceArlene B Chapman, Olivier Devuyst, Kai-Uwe Eckardt, et al.
The Prostate|May 5, 2021
Characterization of tumor-associated macrophages in prostate cancer transgenic mouse modelsAmber E de Groot, Kayla V Myers, Timothy E G Krueger, et al.
Kidney International|September 24, 2017
Common Elements in Rare Kidney Diseases: Conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies ConferenceSégolène Aymé, Detlef Bockenhauer, Simon Day, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 10, 2017
Can we further enrich autosomal dominant polycystic kidney disease clinical trials for rapidly progressive patients? Application of the PROPKD score in the TEMPO trialEmilie Cornec-Le Gall, Jaime D Blais, Maria V Irazabal, et al.
Journal of the American Geriatrics Society|July 17, 2013
Inappropriate medication prescriptions in elderly adults surviving an intensive care unit hospitalizationAlessandro Morandi, Eduard Vasilevskis, Pratik P Pandharipande, et al.
Annals of Surgical Oncology|December 11, 2012
Long-term outcomes in patients with radiation-associated angiosarcomas of the breast following surgery and radiotherapy for breast cancerKeila E Torres, Vinod Ravi, Katherine Kin, et al.
Kidney International|June 14, 2013
Evidence of a third ADPKD locus is not supported by re-analysis of designated PKD3 familiesBinu M Paul, Mark B Consugar, Moonnoh Ryan Lee, et al.
Journal of the American Society of Nephrology : JASN|June 22, 2007
Comprehensive molecular diagnostics in autosomal dominant polycystic kidney diseaseSandro Rossetti, Mark B Consugar, Arlene B Chapman, et al.
Pageof 125